Pasireotide Extended-Release Injection and Triamterene and hydrochlorothiazide
Determining the interaction of Pasireotide Extended-Release Injection and Triamterene and hydrochlorothiazide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: hydrochlorothiazide / triamterene
Brand name: Dyazide, Maxzide, Maxzide-25
Synonyms: Hydrochlorothiazide and triamterene, Hydrochlorothiazide and Triamterene
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Triamterene and Hydrochlorothiazide Capsules
- Pasireotide Extended-Release Injection-Triamterene Capsules
- Pasireotide Extended-Release Injection-Trianex
- Pasireotide Extended-Release Injection-Trianex Ointment
- Pasireotide Extended-Release Injection-Trianide Mild-Cream
- Pasireotide Extended-Release Injection-Triant-HC
- Triamterene and hydrochlorothiazide-Pasireotide Injection
- Triamterene and hydrochlorothiazide-Pasireotide Subcutaneous
- Triamterene and hydrochlorothiazide-Patanase
- Triamterene and hydrochlorothiazide-Patiromer
- Triamterene and hydrochlorothiazide-Patiromer Sorbitex Calcium
- Triamterene and hydrochlorothiazide-Pavacot